文献速递癫痫神经重症与神经感染

麻醉药物剂量递增与难治性癫痫持续状态患者结局之间的关联

Association Between Dose Escalation of Anesthetics and Outcomes in Patients With Refractory Status Epilepticus.
PubMed 文献 · Neurology · 2023-12-15

研究纳入2011至2019年瑞士某学术医疗中心111例无缺氧缺血性脑病的难治性癫痫持续状态成人患者,57%出现麻醉药物剂量递增。多变量分析显示剂量递增与死亡 odds 降低相关(OR 0.09,95%CI 0.01-0.86),幸存者神经功能结局与未递增者相似。

要点

  • 57%的难治性癫痫持续状态患者接受了麻醉药物剂量递增。
  • 剂量递增组多变量分析死亡 odds 降低(OR 0.09,95%CI 0.01-0.86)。
  • 剂量递增组幸存者神经功能结局与未递增组相似。

核心结论

  • 成人难治性癫痫持续状态中,麻醉药物剂量递增与死亡 odds 降低相关,且未增加幸存者神经功能状态差于发作前的比例。

研究设计与样本

  • 评估2011至2019年瑞士某学术医疗中心接受麻醉药物治疗的难治性癫痫持续状态且无缺氧缺血性脑病的成人患者的临床与脑电图数据。
  • 主要终点为麻醉药物剂量递增频率及其与院内死亡或恢复至病前神经功能的关联,采用多变量 logistic 回归分析。

主要发现

  • 111例难治性癫痫持续状态患者中,57%出现麻醉药物剂量递增。
  • 剂量递增组较未递增组有更高的发病率(癫痫持续状态起病时格拉斯哥昏迷量表评分更低、更多推测致命病因、癫痫持续状态和重症监护持续时间更长、更多感染和动脉低血压)。
  • 单变量分析中,两组主要终点无差异。
  • 多变量分析显示剂量递增与死亡 odds 降低相关(OR 0.09,95%CI 0.01-0.86),独立于初始格拉斯哥昏迷量表评分、推测致命病因、癫痫持续状态严重程度评分、癫痫持续状态持续时间及伴昏迷的非惊厥性癫痫持续状态。
  • 剂量递增组幸存者与未递增组幸存者功能结局相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: To investigate the association between dose escalation of continuously administered IV anesthetics and its duration with short-term outcomes in adult patients treated for refractory status epilepticus (RSE). METHODS: Clinical and electroencephalographic data of patients with RSE without hypoxic-ischemic encephalopathy who were treated with anesthetics at a Swiss academic medical center from 2011 to 2019 were assessed. The frequency of anesthetic dose escalation (i.e., dose increase) and its associations with in-hospital death or return to premorbid neurologic function were primary endpoints. Multivariable logistic regression analysis was performed to identify associations with endpoints. RESULTS: Among 111 patients with RSE, doses of anesthetics were escalated in 57%. Despite patients with dose escalation having a higher morbidity (lower Glasgow Coma Scale [GCS] score at status epilepticus [SE] onset, more presumably fatal etiologies, longer duration of SE and intensive care, more infections, and arterial hypotension) as compared with patients without, the primary endpoints did not differ between these groups in univariable analyses. Multivariable analyses revealed decreased odds for death with dose escalation (odds ratio 0.09, 95% CI 0.01-0.86), independent of initial GCS score, presumably fatal etiology, SE severity score, SE duration, and nonconvulsive SE with coma, with similar functional outcome among survivors compared with patients without dose escalation. DISCUSSION: Our study reveals that anesthetic dose escalation in adult patients with RSE is associated with decreased odds for death without increasing the proportion of surviving patients with worse neurofunctional state than before RSE. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that anesthetic dose escalation decreases the odds of death in patients with RSE.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Fisch U, Jünger AL, Baumann SM, et al. Association Between Dose Escalation of Anesthetics and Outcomes in Patients With Refractory Status Epilepticus. Neurology. 2023. PMID: 38165316. doi:10.1212/WNL.0000000000207995

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。